Page last updated: 2024-09-04

sodium salicylate and Cancer of Pancreas

sodium salicylate has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Callery, MP; Carrigan, RC; McDade, TP; Perugini, RA; Vittimberga, FJ	1

Other Studies

1 other study(ies) available for sodium salicylate and Cancer of Pancreas

Article	Year
Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. The Journal of surgical research, 1999, May-01, Volume: 83, Issue:1 Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Cell Nucleus; DNA Fragmentation; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Humans; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Pancreatic Neoplasms; Phosphorylation; Sodium Salicylate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1999

Article

Year

Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.

The Journal of surgical research, 1999, May-01, Volume: 83, Issue:1

Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Cell Nucleus; DNA Fragmentation; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Humans; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Pancreatic Neoplasms; Phosphorylation; Sodium Salicylate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1999